Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ROSUVASTATIN Cause International normalised ratio fluctuation? 11 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 11 reports of International normalised ratio fluctuation have been filed in association with ROSUVASTATIN (Rosuvastatin Calcium). This represents 0.0% of all adverse event reports for ROSUVASTATIN.

11
Reports of International normalised ratio fluctuation with ROSUVASTATIN
0.0%
of all ROSUVASTATIN reports
0
Deaths
7
Hospitalizations

How Dangerous Is International normalised ratio fluctuation From ROSUVASTATIN?

Of the 11 reports, 7 (63.6%) required hospitalization.

Is International normalised ratio fluctuation Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ROSUVASTATIN. However, 11 reports have been filed with the FAERS database.

What Other Side Effects Does ROSUVASTATIN Cause?

Myalgia (3,958) Dyspnoea (2,832) Pain (2,758) Drug ineffective (2,347) Fatigue (2,208) Rhabdomyolysis (2,173) Arthralgia (1,879) Asthma (1,843) Muscle spasms (1,843) Pain in extremity (1,686)

What Other Drugs Cause International normalised ratio fluctuation?

WARFARIN (738) ADALIMUMAB (167) METHOTREXATE (159) BISOPROLOL (155) LEFLUNOMIDE (150) CELECOXIB (149) LEVOFLOXACIN (149) NORFLOXACIN (149) PREDNISONE (149) CEFACLOR (148)

Which ROSUVASTATIN Alternatives Have Lower International normalised ratio fluctuation Risk?

ROSUVASTATIN vs ROSUVASTATIN\ROSUVASTATIN ROSUVASTATIN vs ROTIGOTINE ROSUVASTATIN vs ROXADUSTAT ROSUVASTATIN vs ROXICODONE ROSUVASTATIN vs ROXITHROMYCIN

Related Pages

ROSUVASTATIN Full Profile All International normalised ratio fluctuation Reports All Drugs Causing International normalised ratio fluctuation ROSUVASTATIN Demographics